{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:18:21Z","timestamp":1761895101960},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,6,25]],"date-time":"2010-06-25T00:00:00Z","timestamp":1277424000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>Camptocormia refers to an abnormal posture with flexion of the thoraco-lumbar spine which increases during walking and resolves in supine position. This symptom is an increasingly recognized feature of parkinsonian and dystonic disorders, but may also be caused by neuromuscular diseases. There is recent evidence that both central and peripheral mechanisms may be involved in the pathogenesis of camptocormia. We report a case of acute onset of camptocormia, a rare side effect induced by olanzapine, a second-generation atypical anti-psychotic drug with fewer extra-pyramidal side-effects, increasingly used as first line therapy for schizophrenia, delusional disorders and bipolar disorder.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>A 73-year-old Caucasian woman with no history of neuromuscular disorder, treated for chronic delusional disorder for the last ten years, received two injections of long-acting haloperidol. She was then referred for fatigue. Physical examination showed a frank parkinsonism without other abnormalities. Routine laboratory tests showed normal results, notably concerning creatine kinase level. Fatigue was attributed to haloperidol which was substituted for olanzapine. Our patient left the hospital after five days without complaint. She was admitted again three days later with acute back pain. Examination showed camptocormia and tenderness in paraspinal muscles. Creatine kinase level was elevated (2986 UI\/L). Magnetic resonance imaging showed necrosis and edema in paraspinal muscles. Olanzapine was discontinued. Pain resolved quickly and muscle enzymes were normalized within ten days. Risperidone was later introduced without significant side-effect. The camptocormic posture had disappeared when the patient was seen as an out-patient one year later.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Camptocormia is a heterogeneous syndrome of various causes. We believe that our case illustrates the need to search for paraspinal muscle damage, including drug-induced rhabdomyolysis, in patients presenting with acute-onset bent spine syndrome. Although rare, the occurrence of camptocormia induced by olanzapine must be considered.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1752-1947-4-192","type":"journal-article","created":{"date-parts":[[2010,6,26]],"date-time":"2010-06-26T06:13:49Z","timestamp":1277532829000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Acute camptocormia induced by olanzapine: a case report"],"prefix":"10.1186","volume":"4","author":[{"given":"Florence","family":"Robert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martial","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lie","family":"Robert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Cath\u00e9bras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Philippe","family":"Camdessanch\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,25]]},"reference":[{"key":"1149_CR1","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1097\/00007632-199907150-00017","volume":"24","author":"K Karbowski","year":"1999","unstructured":"Karbowski K: The old and the new camptocormia. Spine. 1999, 24: 1494-1498. 10.1097\/00007632-199907150-00017.","journal-title":"Spine"},{"key":"1149_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1212\/01.wnl.0000171857.09079.9f","volume":"65","author":"SN Azher","year":"2005","unstructured":"Azher SN, Jankovic J: Camptocormia. Pathogenesis, classification, and response to therapy. Neurology. 2005, 65: 355-359. 10.1212\/01.wnl.0000171857.09079.9f.","journal-title":"Neurology"},{"key":"1149_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1136\/jnnp.60.1.51","volume":"60","author":"G Serratrice","year":"1996","unstructured":"Serratrice G, Pouget J, Pellissier JF: Bent spine syndrome. J Neurol Neurosurg Psychiatry. 1996, 60: 51-54. 10.1136\/jnnp.60.1.51.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1149_CR4","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1136\/jnnp.2006.099184","volume":"77","author":"R Djaldetti","year":"2006","unstructured":"Djaldetti R, Melamed E: Camptocormia in Parkinson's disease: new insights. J Neurol Neurosurg Psychiatry. 2006, 77: 1205-10.1136\/jnnp.2006.099184.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1149_CR5","first-page":"51","volume":"42","author":"RR Conley","year":"2005","unstructured":"Conley RR, Kelly DL: Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects. Isr J Psychiatry Relat Sci. 2005, 42: 51-60.","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"1149_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1517\/14740338.2.1.21","volume":"2","author":"DK Farver","year":"2003","unstructured":"Farver DK: Neuroleptic malignant syndrome induced by atypical antipsychotics. Expert Opin Drug Saf. 2003, 2: 21-35. 10.1517\/14740338.2.1.21.","journal-title":"Expert Opin Drug Saf"},{"key":"1149_CR7","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1345\/aph.10370","volume":"35","author":"CJ Rosebraught","year":"2001","unstructured":"Rosebraught CJ, Flockhart DA, Yasuda SU, Woosley RL: Olanzapine-induced rhabdomyolysis. Ann Pharmacother. 2001, 35: 1020-1023. 10.1345\/aph.10370.","journal-title":"Ann Pharmacother"},{"key":"1149_CR8","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1177\/0960327106073832","volume":"25","author":"WS Waring","year":"2006","unstructured":"Waring WS, Wrate J, Bateman DN: Olanzapine overdose is associated with acute muscle toxicity. Hum Exp Toxicol. 2006, 25: 735-740. 10.1177\/0960327106073832.","journal-title":"Hum Exp Toxicol"},{"key":"1149_CR9","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1097\/00007632-199505000-00007","volume":"20","author":"M Laroche","year":"1995","unstructured":"Laroche M, Delisle MB, Aziza R, Lagarrigue J, Mazieres B: Is camptocormia a primary muscular disease?. Spine. 1995, 20: 1011-1016. 10.1097\/00007632-199505000-00007.","journal-title":"Spine"},{"key":"1149_CR10","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/mds.10385","volume":"18","author":"WR Sch\u00e4bitz","year":"2003","unstructured":"Sch\u00e4bitz WR, Glatz K, Schuhan C, Sommer C, Berger C, Schwaninger M, Hartmann M, Hilmar Goebel H, Meinck HM: Severe forward flexion of the trunk in Parkinson's disease: focal myopathy of the paraspinal muscles mimicking camptocormia. Mov Disord. 2003, 18: 408-414. 10.1002\/mds.10385.","journal-title":"Mov Disord"},{"key":"1149_CR11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S0248-8663(01)00530-6","volume":"23","author":"V Delcey","year":"2002","unstructured":"Delcey V, Hachulla E, Michon-Pasturel U, Queyrel V, Hatron PY, Boutry N, Lemaitre V, Vanhille P, Serratrice J, Disdier P, Juhan V, Devulder B, Th\u00e9venon A: La camptocormie: un signe de myopathie axiale. A propos de 7 observations. Rev Med Interne. 2002, 23: 144-154. 10.1016\/S0248-8663(01)00530-6.","journal-title":"Rev Med Interne"},{"key":"1149_CR12","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1212\/WNL.45.5.993","volume":"45","author":"E Hund","year":"1995","unstructured":"Hund E, Heckl R, Goebel HH, Meinck HM: Inclusion body myositis presenting with isolated erector spinae paresis. Neurology. 1995, 45: 993-994.","journal-title":"Neurology"},{"key":"1149_CR13","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1136\/jnnp.2005.083998","volume":"77","author":"AC Lepoutre","year":"2006","unstructured":"Lepoutre AC, Devos D, Blanchard-Dauphin A, Pardessus V, Maurage CA, Ferriby D, Hurtevent JF, Cotten A, Dest\u00e9e A, Defebvre L: A specific clinical pattern of camptocormia in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2006, 77: 1229-1234. 10.1136\/jnnp.2005.083998.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1149_CR14","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/mds.20686","volume":"21","author":"NJ Diederich","year":"2006","unstructured":"Diederich NJ, Goebel HH, Dooms G, Bumb A, Huber F, Kompoliti K, Meinck HM: Camptocormia associated with focal myositis in multiple-system atrophy. Mov Disord. 2006, 21: 390-394. 10.1002\/mds.20686.","journal-title":"Mov Disord"},{"key":"1149_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/PHM.0b013e31802b8bde","volume":"86","author":"F Ozer","year":"2007","unstructured":"Ozer F, Ozturk O, Meral H, Serdaroglu P, Yayla V: Camptocormia in a patient with Parkinson disease and a myopathy with nemaline rods. Am J Phys Med Rehabil. 2007, 86: 3-6. 10.1097\/PHM.0b013e31802b8bde.","journal-title":"Am J Phys Med Rehabil"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-4-192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1752-1947-4-192\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-4-192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-4-192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T05:49:37Z","timestamp":1630475377000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/1752-1947-4-192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,25]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1149"],"URL":"https:\/\/doi.org\/10.1186\/1752-1947-4-192","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,25]]},"assertion":[{"value":"2 December 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"192"}}